GE HealthCare Technologies Inc. (GEHC)
NASDAQ: GEHC · Real-Time Price · USD
70.84
+0.20 (0.28%)
Aug 5, 2025, 10:12 AM - Market open
Verve Therapeutics Market Cap
GEHC has a market cap or net worth of $32.34 billion as of August 5, 2025. Its market cap has decreased by -12.50% in one year.
Market Cap
32.34B
Enterprise Value
39.23B
1-Year Change
-12.50%
Ranking
Category
Stock Price
$70.84
Market Cap Chart
Since December 15, 2022, GEHC's market cap has increased from $6.00K to $32.34B, an increase of 539,047,478.35%. That is a compound annual growth rate of 35,499.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2025 | 32.25B | -9.71% |
| Dec 31, 2024 | 35.72B | 1.47% |
| Dec 29, 2023 | 35.20B | 32.60% |
| Dec 30, 2022 | 26.55B | 442,432,733.90% |
| Dec 15, 2022 | 6.00K | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.37B |
| Johnson & Johnson | 402.99B |
| AbbVie | 344.84B |
| AstraZeneca | 228.08B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 221.54B |
| UnitedHealth Group | 215.69B |
| Novo Nordisk | 211.90B |